FDA announces recall of Stryker cutting guide for TKAOn April 19, the U.S. Food and Drug Administration (FDA) announced that Stryker Orthopaedics has recalled ShapeMatch Cutting Guides, used in total knee arthroplasty…
FDA approves new diabetes drugOn March 29, the U.S. Food and Drug Administration (FDA) approved Invokana (canagliflozin) tablets to treat adults with type 2 diabetes. Invokana has been…
FDA announces recall of drug products from Med Prep ConsultingOn March 18, the U.S. Food and Drug Administration (FDA) announced a voluntary nationwide recall of all lots of all products produced by Med…
FDA encourages prescribers to seek education on prescribing opioid pain medsOn March 1, 2013, the U.S. Food and Drug Administration (FDA) announced that it is joining health professional organizations in encouraging prescribers to seek…
FDA approves Pomalyst for advanced multiple myelomaOn Feb. 8, 2013, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease has progressed…
FDA approves new silicone breast implantOn Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant for…
FDA approves first retinal implant for adults with advanced retinitis pigmentosaOn Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Argus II Retinal Prosthesis System, the first implanted device to treat…
FDA approves Osphena for postmenopausal women with dyspareuniaOn Feb. 26, 2013, the U.S. Food and Drug Administration (FDA) approved Osphena (ospemifene) to treat women with moderate to severe dyspareunia (pain during…
FDA approves new drug treatments for type 2 diabetesOn Jan. 25, 2013, the U.S. Food and Drug Administration (FDA) approved three new related products for the treatment of type 2 diabetes: Nesina…
FDA approves seasonal flu vaccine made using novel technologyOn Jan. 16, 2012, the U.S. Food and Drug Administration (FDA) approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus)…
FDA approves Botox for treatment of overactive bladderOn Jan. 18, 2013, the U.S. Food and Drug Administration (FDA) approved the use of Botox (onabotulinumtoxinA) to treat adults with overactive bladder who…
FDA issue draft guidance on making opioids harder to abuseOn Jan. 9, 2012, the U.S. Food and Drug Administration (FDA) issued a draft guidance document to assist industry in developing new formulations of…
FDA announces recall of Stryker cutting guide for TKAOn April 19, the U.S. Food and Drug Administration (FDA) announced that Stryker Orthopaedics has recalled ShapeMatch Cutting Guides, used in total…
FDA approves new diabetes drugOn March 29, the U.S. Food and Drug Administration (FDA) approved Invokana (canagliflozin) tablets to treat adults with type 2 diabetes. Invokana…
FDA announces recall of drug products from Med Prep ConsultingOn March 18, the U.S. Food and Drug Administration (FDA) announced a voluntary nationwide recall of all lots of all products produced…
FDA encourages prescribers to seek education on prescribing opioid pain medsOn March 1, 2013, the U.S. Food and Drug Administration (FDA) announced that it is joining health professional organizations in encouraging prescribers…
FDA approves Pomalyst for advanced multiple myelomaOn Feb. 8, 2013, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease…
FDA approves new silicone breast implantOn Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast…
FDA approves first retinal implant for adults with advanced retinitis pigmentosaOn Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Argus II Retinal Prosthesis System, the first implanted device…
FDA approves Osphena for postmenopausal women with dyspareuniaOn Feb. 26, 2013, the U.S. Food and Drug Administration (FDA) approved Osphena (ospemifene) to treat women with moderate to severe dyspareunia…
FDA approves new drug treatments for type 2 diabetesOn Jan. 25, 2013, the U.S. Food and Drug Administration (FDA) approved three new related products for the treatment of type 2…
FDA approves seasonal flu vaccine made using novel technologyOn Jan. 16, 2012, the U.S. Food and Drug Administration (FDA) approved Flublok, the first trivalent influenza vaccine made using an insect…
FDA approves Botox for treatment of overactive bladderOn Jan. 18, 2013, the U.S. Food and Drug Administration (FDA) approved the use of Botox (onabotulinumtoxinA) to treat adults with overactive…
FDA issue draft guidance on making opioids harder to abuseOn Jan. 9, 2012, the U.S. Food and Drug Administration (FDA) issued a draft guidance document to assist industry in developing new…
